Literature DB >> 21968609

Formulation of diblock polymeric nanoparticles through nanoprecipitation technique.

Shrirang Karve1, Michael E Werner, Natalie D Cummings, Rohit Sukumar, Edina C Wang, Ying-Ao Zhang, Andrew Z Wang.   

Abstract

Nanotechnology is a relatively new branch of science that involves harnessing the unique properties of particles that are nanometers in scale (nanoparticles). Nanoparticles can be engineered in a precise fashion where their size, composition and surface chemistry can be carefully controlled. This enables unprecedented freedom to modify some of the fundamental properties of their cargo, such as solubility, diffusivity, biodistribution, release characteristics and immunogenicity. Since their inception, nanoparticles have been utilized in many areas of science and medicine, including drug delivery, imaging, and cell biology(1-4). However, it has not been fully utilized outside of "nanotechnology laboratories" due to perceived technical barrier. In this article, we describe a simple method to synthesize a polymer based nanoparticle platform that has a wide range of potential applications. The first step is to synthesize a diblock co-polymer that has both a hydrophobic domain and hydrophilic domain. Using PLGA and PEG as model polymers, we described a conjugation reaction using EDC/NHS chemistry(5) (Fig 1). We also discuss the polymer purification process. The synthesized diblock co-polymer can self-assemble into nanoparticles in the nanoprecipitation process through hydrophobic-hydrophilic interactions. The described polymer nanoparticle is very versatile. The hydrophobic core of the nanoparticle can be utilized to carry poorly soluble drugs for drug delivery experiments6. Furthermore, the nanoparticles can overcome the problem of toxic solvents for poorly soluble molecular biology reagents, such as wortmannin, which requires a solvent like DMSO. However, DMSO can be toxic to cells and interfere with the experiment. These poorly soluble drugs and reagents can be effectively delivered using polymer nanoparticles with minimal toxicity. Polymer nanoparticles can also be loaded with fluorescent dye and utilized for intracellular trafficking studies. Lastly, these polymer nanoparticles can be conjugated to targeting ligands through surface PEG. Such targeted nanoparticles can be utilized to label specific epitopes on or in cells(7-10).

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21968609      PMCID: PMC3230208          DOI: 10.3791/3398

Source DB:  PubMed          Journal:  J Vis Exp        ISSN: 1940-087X            Impact factor:   1.355


  14 in total

1.  PEGylated PLGA nanoparticles as protein carriers: synthesis, preparation and biodistribution in rats.

Authors:  Y Li; Y Pei; X Zhang; Z Gu; Z Zhou; W Yuan; J Zhou; J Zhu; X Gao
Journal:  J Control Release       Date:  2001-04-02       Impact factor: 9.776

2.  Biodegradable block copolymers as injectable drug-delivery systems.

Authors:  B Jeong; Y H Bae; D S Lee; S W Kim
Journal:  Nature       Date:  1997-08-28       Impact factor: 49.962

Review 3.  Freeze-drying of nanoparticles: formulation, process and storage considerations.

Authors:  Wassim Abdelwahed; Ghania Degobert; Serge Stainmesse; Hatem Fessi
Journal:  Adv Drug Deliv Rev       Date:  2006-10-06       Impact factor: 15.470

4.  Drug release from biodegradable injectable thermosensitive hydrogel of PEG-PLGA-PEG triblock copolymers.

Authors:  B Jeong; Y H Bae; S W Kim
Journal:  J Control Release       Date:  2000-01-03       Impact factor: 9.776

5.  Targeted biocompatible nanoparticles for the delivery of (-)-epigallocatechin 3-gallate to prostate cancer cells.

Authors:  Vanna Sanna; Gianfranco Pintus; Anna Maria Roggio; Stefania Punzoni; Anna Maria Posadino; Alessandro Arca; Salvatore Marceddu; Pasquale Bandiera; Sergio Uzzau; Mario Sechi
Journal:  J Med Chem       Date:  2011-02-09       Impact factor: 7.446

6.  Folate receptor targeted biodegradable polymeric doxorubicin micelles.

Authors:  Hyuk Sang Yoo; Tae Gwan Park
Journal:  J Control Release       Date:  2004-04-28       Impact factor: 9.776

7.  Precise engineering of targeted nanoparticles by using self-assembled biointegrated block copolymers.

Authors:  Frank Gu; Liangfang Zhang; Benjamin A Teply; Nina Mann; Andrew Wang; Aleksandar F Radovic-Moreno; Robert Langer; Omid C Farokhzad
Journal:  Proc Natl Acad Sci U S A       Date:  2008-02-13       Impact factor: 11.205

8.  Biodegradable long-circulating polymeric nanospheres.

Authors:  R Gref; Y Minamitake; M T Peracchia; V Trubetskoy; V Torchilin; R Langer
Journal:  Science       Date:  1994-03-18       Impact factor: 47.728

Review 9.  Biofunctionalized targeted nanoparticles for therapeutic applications.

Authors:  Andrew Z Wang; Frank Gu; Liangfang Zhang; Juliana M Chan; Aleksander Radovic-Moreno; Mariam R Shaikh; Omid C Farokhzad
Journal:  Expert Opin Biol Ther       Date:  2008-08       Impact factor: 4.388

Review 10.  Biomimetic polymers in pharmaceutical and biomedical sciences.

Authors:  S Drotleff; U Lungwitz; M Breunig; A Dennis; T Blunk; J Tessmar; A Göpferich
Journal:  Eur J Pharm Biopharm       Date:  2004-09       Impact factor: 5.571

View more
  4 in total

1.  Nanoparticles in thermosensitive gel based composite nanosystem for ocular diseases.

Authors:  Vibhuti Agrahari; Sulabh P Patel; Nikhil Dhall; Zach Aulgur; Siddhant Thukral; Xiaoyan Yang; Ryan Conley; Ashim K Mitra
Journal:  Drug Deliv Transl Res       Date:  2018-04       Impact factor: 4.617

2.  Enhanced immunosuppressive effects of 3,5-bis[4(diethoxymethyl)benzylidene]-1-methyl-piperidin-4-one, an α, β-unsaturated carbonyl-based compound as PLGA-b-PEG nanoparticles.

Authors:  Laiba Arshad; Ibrahim Jantan; Syed Nasir Abbas Bukhari
Journal:  Drug Des Devel Ther       Date:  2019-04-30       Impact factor: 4.162

3.  Comparison of bulk and microfluidics methods for the formulation of poly-lactic-co-glycolic acid (PLGA) nanoparticles modified with cell-penetrating peptides of different architectures.

Authors:  Sarah Streck; Henriette Neumann; Hanne Mørck Nielsen; Thomas Rades; Arlene McDowell
Journal:  Int J Pharm X       Date:  2019-08-13

4.  PLGA nanoparticle encapsulation reduces toxicity while retaining the therapeutic efficacy of EtNBS-PDT in vitro.

Authors:  Hsin-I Hung; Oliver J Klein; Sam W Peterson; Sarah R Rokosh; Sam Osseiran; Nicholas H Nowell; Conor L Evans
Journal:  Sci Rep       Date:  2016-09-30       Impact factor: 4.379

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.